9WM
AZN icon

9258 Wealth Management’s AstraZeneca AZN Stock Holding History

9258 Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.05M Sell
6,729
-235
-3% -$37.9K 0.16% 118
2024
Q2 		$1.09M Buy
6,964
+754
+12% +$113K 0.17% 111
2024
Q1 		$841K Sell
6,210
-80
-1% -$10.6K 0.13% 141
2023
Q4 		$847K Sell
6,290
-153
-2% -$19.9K 0.15% 131
2023
Q3 		$873K Buy
6,443
+91
+1% +$12.4K 0.17% 118
2023
Q2 		$909K Buy
6,352
+7
+0.1% +$1.03K 0.17% 114
2023
Q1 		$881K Sell
6,345
-176
-3% -$23.7K 0.18% 108
2022
Q4 		$884K Sell
6,521
-254
-4% -$31.9K 0.19% 103
2022
Q3 		$743K Sell
6,775
-531
-7% -$67.4K 0.19% 115
2022
Q2 		$965K Sell
7,306
-38
-0.5% -$4.99K 0.25% 97
2022
Q1 		$974K Buy
7,344
+35
+0.5% +$4.2K 0.23% 104
2021
Q4 		$851K Buy
7,309
+48
+0.7% +$5.65K 0.2% 127
2021
Q3 		$872K Buy
7,261
+2,599
+56% +$303K 0.23% 106
2021
Q2 		$559K Buy
4,662
+267
+6% +$29.3K 0.15% 148
2021
Q1 		$437K Buy
4,395
+333
+8% +$33.5K 0.13% 171
2020
Q4 		$406K Buy
4,062
+690
+20% +$73.1K 0.13% 175
2020
Q3 		$338K Sell
3,372
-101
-3% -$11.2K 0.13% 186
2020
Q2 		$367K Buy
3,473
+50
+1% +$5.16K 0.15% 168
2020
Q1 		$352K Sell
3,423
-209
-6% -$19.7K 0.15% 162
2019
Q4 		$362K Buy
+3,632
New +$342K 0.13% 191

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

9258 Wealth Management's AZN Position: Q3 2024 in Review

9258 Wealth Management reduced its AstraZeneca (AZN) stake by 3.4% in Q3 2024, selling an estimated $37.9K and leaving 6,729 shares worth $1.05M. The position accounts for 0.16% of the portfolio, ranked #118.

9258 Wealth Management first reported a position in AZN in Q4 2019 and has held it in 20 quarters since. The position peaked at $1.09M in Q2 2024. 1,229 funds tracked by Wall St. Rank hold AZN as of Q3 2024.

  • 9258 Wealth Management held 6,729 shares of AstraZeneca worth $1.05M as of Q3 2024.
  • 9258 Wealth Management sold 235 AstraZeneca shares in Q3 2024, an estimated $37.9K.
  • AstraZeneca made up 0.16% of 9258 Wealth Management's portfolio in Q3 2024, its #118 holding.
  • 9258 Wealth Management first reported a position in AstraZeneca in Q4 2019 and has held it in 20 quarters since.
  • 9258 Wealth Management's AstraZeneca position peaked at $1.09M in Q2 2024.
  • 1,229 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2024.

Based on 9258 Wealth Management's 13F filing for Q3 2024, filed 12 Nov 2024.